LanzaTech Global Files 8-K

Ticker: LNZAW · Form: 8-K · Filed: Oct 1, 2024 · CIK: 1843724

Lanzatech Global, INC. 8-K Filing Summary
FieldDetail
CompanyLanzatech Global, INC. (LNZAW)
Form Type8-K
Filed DateOct 1, 2024
Risk Levellow
Pages2
Reading Time2 min
Key Dollar Amounts$0.0001, $11.50
Sentimentneutral

Sentiment: neutral

Topics: sec-filing, corporate-update

Related Tickers: LTZA

TL;DR

LanzaTech Global (LTZA) filed an 8-K on Oct 1st. No major news, just routine reporting.

AI Summary

LanzaTech Global, Inc. filed an 8-K on October 1, 2024, reporting on other events and financial statements. The company, formerly known as AMCI Acquisition Corp. II, is incorporated in Delaware and headquartered in Skokie, Illinois.

Why It Matters

This filing provides an update on LanzaTech Global's corporate and financial reporting status with the SEC.

Risk Assessment

Risk Level: low — This is a routine SEC filing with no new material financial information or significant corporate events disclosed.

Key Numbers

Key Players & Entities

FAQ

What is the primary purpose of this 8-K filing?

The primary purpose of this 8-K filing is to report on 'Other Events' and 'Financial Statements and Exhibits' as of October 1, 2024.

When was LanzaTech Global, Inc. formerly known as?

LanzaTech Global, Inc. was formerly known as AMCI Acquisition Corp. II.

What is LanzaTech Global's principal executive office address?

LanzaTech Global's principal executive office is located at 8045 Lamon Avenue, Suite 400, Skokie, Illinois 60077.

What is the SEC file number for LanzaTech Global?

The SEC file number for LanzaTech Global is 001-40282.

What is the date of the earliest event reported in this filing?

The date of the earliest event reported in this filing is October 1, 2024.

Filing Stats: 500 words · 2 min read · ~2 pages · Grade level 10.7 · Accepted 2024-10-01 07:15:45

Key Financial Figures

Filing Documents

01. Other Event

Item 8.01. Other Event. Chicago, IL (October 1, 2024) – LanzaTech Global, Inc. (Nasdaq: LNZA) issued a press release announcing the expansion of its biorefining platform capabilities to include the primary production of commercial-scale nutritional protein produced directly from CO 2 . The Company also made available on its website a presentation that discusses the content included in the press release. Copies of the Company's press release and presentation are attached as Exhibits 99.1 and 99.2 to this Form 8-K.

01. Financial Statements and Exhibits

Item 9.01. Financial Statements and Exhibits. (d) Exhibits Exhibit Number Description 99.1 Press release announcing LanzaTech Nutritional Protein dated October 1, 2024 99.2 Presentation on LanzaTech Nutritional Protein dated October 1, 2024 104 Cover Page Interactive Data File (embedded within the Inline XBRL document). 2

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Dated: October 1, 2024 LANZATECH GLOBAL, INC. By: /s/ Joseph Blasko Name: Joseph Blasko Title: General Counsel and Corporate Secretary 3

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing